ID   SB.07
AC   CVCL_VJ94
SY   SB_07
DR   cancercelllines; CVCL_VJ94
DR   Cosmic; 2498853
DR   Wikidata; Q98129338
RX   PubMed=26962861;
CC   Doubling time: 50.3 hours (PubMed=26962861).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=26962861).
CC   Omics: Genome sequenced.
CC   Derived from site: Metastatic; Ileal lymph node; UBERON=UBERON_0037522.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
RX   PubMed=26962861; DOI=10.1371/journal.pone.0149833; PMCID=PMC4786220;
RA   Sorber R., Teper Y., Abisoye-Ogunniyan A., Waterfall J.J., Davis S.,
RA   Killian J.K., Pineda M.A., Ray S., McCord M.R., Pflicke H.,
RA   Burkett S.S., Meltzer P.S., Rudloff U.;
RT   "Whole genome sequencing of newly established pancreatic cancer lines
RT   identifies novel somatic mutation (c.2587G>A) in axon guidance
RT   receptor plexin A1 as enhancer of proliferation and invasion.";
RL   PLoS ONE 11:E0149833-E0149833(2016).
//